These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 33857342)

  • 1. Comparative effectiveness and safety of anticoagulants for the treatment of heparin-induced thrombocytopenia.
    Nilius H; Kaufmann J; Cuker A; Nagler M
    Am J Hematol; 2021 Jul; 96(7):805-815. PubMed ID: 33857342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Fondaparinux Off-Label or Approved Anticoagulants for Management of Heparin-Induced Thrombocytopenia.
    Schindewolf M; Steindl J; Beyer-Westendorf J; Schellong S; Dohmen PM; Brachmann J; Madlener K; Pötzsch B; Klamroth R; Hankowitz J; Banik N; Eberle S; Müller MM; Kropff S; Lindhoff-Last E
    J Am Coll Cardiol; 2017 Nov; 70(21):2636-2648. PubMed ID: 29169470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel fondaparinux protocol for anticoagulation therapy in adults with renal failure and suspected heparin-induced thrombocytopenia: a retrospective review of institutional protocol.
    Ghaziri D; Dehaini H; Msheik M; Bahmad M; Zorkot M; Saad GA
    BMC Pharmacol Toxicol; 2023 Jan; 24(1):2. PubMed ID: 36639796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy and safety of direct oral anticoagulants in the treatment of the acute phase of heparin-induced thrombocytopenia: A systematic review.
    Sadowski C; Reinert JP
    Am J Health Syst Pharm; 2024 Sep; 81(19):e584-e593. PubMed ID: 38651828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia.
    Cuker A; Arepally GM; Chong BH; Cines DB; Greinacher A; Gruel Y; Linkins LA; Rodner SB; Selleng S; Warkentin TE; Wex A; Mustafa RA; Morgan RL; Santesso N
    Blood Adv; 2018 Nov; 2(22):3360-3392. PubMed ID: 30482768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
    Linkins LA; Dans AL; Moores LK; Bona R; Davidson BL; Schulman S; Crowther M
    Chest; 2012 Feb; 141(2 Suppl):e495S-e530S. PubMed ID: 22315270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fondaparinux for the treatment of suspected heparin-induced thrombocytopenia: a propensity score-matched study.
    Kang M; Alahmadi M; Sawh S; Kovacs MJ; Lazo-Langner A
    Blood; 2015 Feb; 125(6):924-9. PubMed ID: 25515959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin-induced thrombocytopenia: pathophysiology, diagnosis and treatment.
    Hvas AM; Favaloro EJ; Hellfritzsch M
    Expert Rev Hematol; 2021 Apr; 14(4):335-346. PubMed ID: 33736552
    [No Abstract]   [Full Text] [Related]  

  • 9. Potential Role of Direct Oral Anticoagulants in the Management of Heparin-induced Thrombocytopenia.
    Barlow A; Barlow B; Reinaker T; Harris J
    Pharmacotherapy; 2019 Aug; 39(8):837-853. PubMed ID: 31233222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of argatroban and bivalirudine in patients with suspected heparin-induced thrombocytopenia.
    Vo QA; Lin JK; Tong LM
    Ann Pharmacother; 2015 Feb; 49(2):178-84. PubMed ID: 25515865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and management of heparin-induced thrombocytopenia: a consensus statement from the Thrombosis and Haemostasis Society of Australia and New Zealand HIT Writing Group.
    Joseph J; Rabbolini D; Enjeti AK; Favaloro E; Kopp MC; McRae S; Pasalic L; Tan CW; Ward CM; Chong BH
    Med J Aust; 2019 Jun; 210(11):509-516. PubMed ID: 31155728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fondaparinux: a potential new therapy for HIT.
    Kuo KH; Kovacs MJ
    Hematology; 2005 Aug; 10(4):271-5. PubMed ID: 16085538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia.
    Dang CH; Durkalski VL; Nappi JM
    Pharmacotherapy; 2006 Apr; 26(4):461-8. PubMed ID: 16553503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin-induced thrombocytopenia--therapeutic concentrations of danaparoid, unlike fondaparinux and direct thrombin inhibitors, inhibit formation of platelet factor 4-heparin complexes.
    Krauel K; Fürll B; Warkentin TE; Weitschies W; Kohlmann T; Sheppard JI; Greinacher A
    J Thromb Haemost; 2008 Dec; 6(12):2160-7. PubMed ID: 18983520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin-induced thrombocytopenia: pathophysiology and new treatment options.
    Harenberg J; Jörg I; Fenyvesi T
    Pathophysiol Haemost Thromb; 2002; 32(5-6):289-94. PubMed ID: 13679659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of bivalirudin to lepirudin and argatroban in patients with heparin-induced thrombocytopenia.
    Bain J; Meyer A
    Am J Health Syst Pharm; 2015 Sep; 72(17 Suppl 2):S104-9. PubMed ID: 26272889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fondaparinux for thromboembolic treatment and prophylaxis of heparin-induced thrombocytopenia.
    Efird LE; Kockler DR
    Ann Pharmacother; 2006; 40(7-8):1383-7. PubMed ID: 16788093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of argatroban and fondaparinux for the management of patients with isolated heparin-induced thrombocytopenia.
    Al-Eidan FAS; Alrawkan S; Alshammary H; Crowther MA
    Ann Hematol; 2018 Nov; 97(11):2055-2059. PubMed ID: 30003318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How we manage patients with heparin induced thrombocytopenia.
    Scully M; Gates C; Neave L
    Br J Haematol; 2016 Jul; 174(1):9-15. PubMed ID: 27097741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of argatroban, danaparoid, and fondaparinux on trombin generation in heparin-induced thrombocytopenia.
    Tardy-Poncet B; Combe M; Piot M; Chapelle C; Akrour M; Tardy B
    Thromb Haemost; 2013 Mar; 109(3):504-9. PubMed ID: 23328916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.